IDEXX rises after raising annual profit forecast
IDXX•IDEXX raises profit outlook and tops estimates
Shares of IDEXX Laboratories IDXX.O rise 2% to $574 premarket.
Veterinary diagnostics maker raises 2026 profit forecast to $14.69-$14.94 per share from $14.45-$14.90 previously; new midpoint of about $14.82 exceeds analysts' estimate of $14.65, according to LSEG data.
Reports Q2 profit of $4.27 per share vs analysts' average estimate of $3.94, according to LSEG data.
Q2 revenue rises 10% to $1.22 bln, above analysts' estimate of $1.20 bln.
As of last close, stock down ~16% YTD.
